Clinical Trials Directory

Trials / Completed

CompletedNCT01206374

Questionnaire and Laboratory Data on Vitiligo Vulgaris

Demographic and Laboratory Data Collection for Patients With Vitiligo Vulgaris

Status
Completed
Phase
Study type
Observational
Enrollment
57 (actual)
Sponsor
St. Luke's-Roosevelt Hospital Center · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to be required for development of vitiligo, only 5-10% of relatives develop disease. The triggers for disease onset have not yet been identified. The intent of this study is to research trends in laboratory data, social and medical history that may be contributory to vitiligo onset, location of disease, course of illness and response to therapy.

Detailed description

Patients who participate in this study will be asked to complete a survey and have blood/ laboratory testing performed that relates or may relate to the diagnosis of vitiligo.

Conditions

Timeline

Start date
2010-08-01
Primary completion
2010-10-01
Completion
2014-09-01
First posted
2010-09-21
Last updated
2015-05-25

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01206374. Inclusion in this directory is not an endorsement.